DRG Epidemiology's coverage of hypertension comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of hypertension for each country, as well as annualized case counts projected to the national population.

In addition to forecasting prevalent patient populations, the number of drug-treatment opportunities at specific lines of therapy are also forecast across the world.

DRG Epidemiology's hypertension forecast will answer the following questions:

  • Of all people with hypertension, how many in each country across the world have been formally diagnosed?
  • Of all people diagnosed with hypertension, how many in each country across the world are drug-treated?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of hypertension over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

In total, DRG Epidemiology forecasts 43 hypertension patient populations, as follows:

  • total prevalent cases hypertension
  • Controlled prevalent cases
  • Controlled prevalent cases
  • Controlled prevalent cases- 1 antihypertensive
  • Controlled prevalent cases- 2 antihypertensives
  • Controlled prevalent cases- 3+ antihypertensives
  • Controlled prevalent cases of htn
  • Diagnosed prevalent cases
  • Diagnosed prevalent cases hypertension
  • Diagnosed prevalent cases of htn
  • … and many more (details available on request).

Note: coverage may vary by country.

Table of contents

  • Hypertension - Epidemiology - Middle East & Africa
    • Introduction
      • Key Findings
        • Prevalence of Hypertension per 100 Among People Aged 20+ in 2020 and 2030
        • Relative Sizes of the Contributing Factors to the Trend in Prevalent Cases of Hypertension over the Next 10 Years
    • Epidemiology Data
    • Methods
      • Total Prevalence of Hypertension
      • Percentage Diagnosed
      • Percentage Drug-Treated
      • Percentage Controlled
    • Reference Materials
      • Literature Review
        • Studies Included in the Analysis of Hypertension
        • Studies Excluded from the Analysis of Hypertension
      • Risk/Protective Factors
        • Risk/Protective Factors for Hypertension
      • Bibliography
        • Glossary

    Author(s): Nishant Kumar, MPH

    Nishant is a senior epidemiologist and head of oncology within the epidemiology team at Decision Resources Group. He also covers some CNS diseases, including Alzheimer’s disease and dementia. His key interests are developing interactive patient flows, and modelling disease progression to forecast commercially relevant drug-treatable incident and prevalent populations. Nishant also spends a lot of time collaborating with clients to help answer more specific questions through custom work and consulting projects.

    His qualifications include an MSc in Public Health with specialization in epidemiology and statistics from King’s College London, and a BSc in Medical Studies from the University of Birmingham.

    Related Reports

    Pulmonary Hypertension - Landscape & Forecast - Disease Landscape & Forecast

    Pulmonary hypertension (PH) is a devastating disease with high levels of morbidity and mortality and no cure. Despite the disease’s rarity, the pot...

    View Details

    Hypertension - Unmet Need - Detailed, Expanded Analysis 2020

    Primary, or essential, hypertension is defined as persistently elevated blood pressure without any identifiable cause. It is a major risk factor for various cardiovascular diseases (e.g., coronary...

    View Details

    Pulmonary Hypertension - Unmet Need - Detailed, Expanded Analysis ( US/EU)

    PAH is a rare, life-threatening disorder marked by considerable morbidity and mortality. Despite the availability of a wide array of drugs...

    View Details

    Hypertension - Current Treatment - Detailed, Expanded Analysis (US)

    Primary, or essential, hypertension is defined as persistently elevated blood pressure (BP) without any identifiable cause. It is a major risk factor for various...

    View Details